Skip to main content
Top Header menu
About us
ALB D&I
Advertisement
Contact Us
Log in
search
Asia
China
India
Admin
Main navigation
News
Breaking News
Appointments
Deals
In House News
Other News
Features and Analysis
News By Jurisdiction
Expert commentary
Rankings
E-Magazines
E-Magazine Archive
Events
In-House Summits
Law Awards
Masterclasses
Partner Events
Forums & Conferences
Find A Firm
Legal Jobs
Virtual Events
Videos
Handbooks
ALB HONG KONG IPO HANDBOOK 2020
ALB ASIA INSOLVENCY & RESTRUCTURING HANDBOOK 2020
ALB LEGAL GUIDE TO THE GREATER BAY AREA 2021
ALB GUIDE TO SHANGHAI STAR MARKET IPOs 2021
Subscribe
Menu
News
Rankings
E-Magazines
Events
Find A Firm
Legal Jobs
Virtual Events
videos
handbooks
subscribe
锐敏、锦天城等助力阿斯利康以12亿美元成功收购亘喜生物(ZH/EN)
BY Hu Yangxiaoxiao 胡阳潇潇 |
26 Feb 24
近日,中国生物科技公司亘喜生物宣布正式完成与阿斯利康集团的合并协议,总交易价值高达12亿美元。